Skip to main content

Table 2 CD4 lymphocytic level changes before and after treatment

From: Safety and efficacy of directly acting antivirals (sofosbuvir and daclatasvir) in treatment of chronic HCV in HIV-HCV co-infected Egyptian patients

Items

CD4 lymphocytic count (mean ± SD)

Before treatment

310.60 ±89.9

End of treatment

385.90 ±108.71

SVR at 12 weeks

445.13 ±125.44

F-value

11.482

P-value

0.0001

Significance

S

  1. SD standard deviation, P-value probability, S significant